AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States

https://www.prnewswire.com/news-releases/acelrx-pharmaceuticals-announces-publication-of-study-evaluating-anticoagulation-practices-for-continuous-renal-replacement-therapy–in-the-united-states-302012467.html

Use of CRRT increased during COVID and remained at these higher utilization levels

Study results demonstrate challenges physicians have with heparin and citrate, the two currently available CRRT anticoagulants 

Read more at prnewswire.com

Related news for (ACRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.